Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Veeva Systems Inc., 3 years.
Veeva Systems Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 3, 2026 | IDEXX Laboratories Inc. | Open-market sale | −1,758 | $634.57 | $1,115,574 |
| Feb 26, 2026 | IDEXX Laboratories Inc. | Open-market sale | −2,693 | $661.54 | $1,781,527 |
| Feb 14, 2026 | IDEXX Laboratories Inc. | Option exercise | +204 | — | — |
| Feb 14, 2026 | IDEXX Laboratories Inc. | Option exercise | +207 | — | — |
| Feb 14, 2026 | IDEXX Laboratories Inc. | Option exercise | +301 | — | — |
| Feb 14, 2026 | IDEXX Laboratories Inc. | Option exercise | +1,508 | — | — |
| Feb 14, 2026 | IDEXX Laboratories Inc. | Option exercise | +367 | — | — |
| Feb 14, 2026 | IDEXX Laboratories Inc. | Shares withheld for tax | −1,154 | $629.35 | $726,270 |
| Nov 7, 2025 | IDEXX Laboratories Inc. | Option exercise | +7,125 | $288.78 | $2,057,558 |
| Nov 7, 2025 | IDEXX Laboratories Inc. | Option exercise | +5,405 | $505.53 | $2,732,390 |
| Nov 7, 2025 | IDEXX Laboratories Inc. | Open-market sale | −5,114 | $702.20 | $3,591,051 |
| Nov 7, 2025 | IDEXX Laboratories Inc. | Open-market sale | −1,465 | $703.73 | $1,030,964 |
| Nov 7, 2025 | IDEXX Laboratories Inc. | Open-market sale | −1,468 | $704.87 | $1,034,749 |
| Nov 7, 2025 | IDEXX Laboratories Inc. | Open-market sale | −1,378 | $705.54 | $972,234 |
| Aug 12, 2025 | IDEXX Laboratories Inc. | Option exercise | +560 | $178.26 | $99,826 |
Questions about Nimrata Hunt
What boards is Nimrata Hunt on?
Nimrata Hunt sits on the board of Veeva Systems Inc.
How long has Nimrata Hunt served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.